Atlas Trials

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Clinical trial NCT03218787 · COMPLETED

Trial details

NCT number
NCT03218787
Sponsor
Abbott Medical Devices
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Lesions
Start date
2017-07-19
Primary completion
2020-09-04
Enrollment
2047

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.